You are here

DISCOVERYBIOMED, INC.

Company Information
Address
400 Riverhills Business Park
BIRMINGHAM, AL 35242-5038
United States


http://www.discoverybiomed.com

Information

UEI: LR7QH452JJ31

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Inhibitors of IgH Gene Enhancers for the Treatment of Multiple Myeloma

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) has launched an innovative and automation-friendly drug discovery program to screen synthetic organic small molecule collections on dif ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  2. DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease

    Amount: $436,560.00

    DESCRIPTION (provided by applicant): An important discovery and validation event occurred recently within human cell-based drug discovery programs at DiscoveryBioMed, Inc. (DBM), yielding a lead clas ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  3. Human Adipocyte Platform for Discovery of Novel Adiponectin Secretagogues

    Amount: $221,853.00

    DESCRIPTION (provided by applicant): Small business concerns, DiscoveryBioMed, Inc. (DBM) and Chromadex, Inc. (CDex), have designed an innovative automation-friendly drug discovery program to screen m ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  4. CF Corrector Ligands Discovered on CF Human Airway Cells

    Amount: $1,379,561.00

    DESCRIPTION (provided by applicant): DiscoveryBioMed, Inc. (DBM) achieved Phase 1 SBIR milestones and seeks to continue a mature program that has progressed to the hit-to-lead drug validation, priorit ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  5. Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells

    Amount: $234,330.00

    DESCRIPTION (provided by applicant): Project Summary Description Title: Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells. Osteoporosis is a growing problem in the aged and an unfortu ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  6. Discovery of Novel Anti-Inflammatory Phytochemicals on Human Cell Platforms

    Amount: $200,000.00

    DESCRIPTION (provided by applicant): Title: Discovery of Novel Anti-Inflammatory Phytochemicals on Human Cell Platforms Project Summary Statement The Problems: Complementary and alternative medi ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  7. Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis

    Amount: $746,326.00

    DESCRIPTION (provided by applicant): Hypertension is a confounding multifactorial disorder that affects millions of patients worldwide. Cystic fibrosis (CF) is an inherited disease of the pulmonary an ...

    SBIRPhase II2009Department of Health and Human Services National Institutes of Health
  8. Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells

    Amount: $322,000.00

    DESCRIPTION (provided by applicant): In this proposed Phase I SBIR program, DiscoveryBioMed, Inc. (DBM) will continue to build upon an active project performed in collaboration with CFTR cell biologis ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  9. Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis Scientific Summary Description Hypertension is a confounding multifactorial disorder that affects ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government